Fig. 2From: Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrationsGenomic instability index (GII) as a function of proliferation score for with good response (GR, green), intermediate response (IR, light blue), and no response (NR, red) tumors for both treatment arms. Significant correlation was observed (Pearson correlation = 0.52, p value < 0.01)Back to article page